It revealed that apoE23 therapy effectively reduced plasma levels of TNF-α, IL-6, and LPS; decreased bacterial load in the spleen tissue homogenate; and alleviated infection-induced lung, liver, and small intestine injuries in mice with sepsis. The gene discussed is TNF; the disease is infection.